Abilita Therapeutics, Inc
Abilita Therapeutics, Inc., based in San Diego, CA, is focused on unlocking the therapeutic potential of membrane protein targets to create transformative treatment options for patients. Utilizing their proprietary Enabled Membrane Protein (EMP) technology, the company enhances the stability and expression of membrane proteins, facilitating the discovery and optimization of drug candidates that have previously been considered intractable or undruggable.
With a significant portion of FDA-approved drugs targeting a limited number of membrane protein targets, Abilita Therapeutics aims to explore the vast potential of hundreds of membrane proteins that remain unaddressed in the market. Their innovative approach not only boosts the probability of developing elusive drugs but also opens new avenues for life-saving therapeutics in various medical fields.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.